참고문헌
- Berardi R, Morgese F, Onofri A, et al (2013). Role of maspin in cancer. Clin Transl Med, 2, 8. https://doi.org/10.1186/2001-1326-2-8
- Chhabra D, Oda K, Jagannath P, et al (2012). Chronic heavy metal exposure and gallbladder cancer risk in India, a comparative study with Japan. Asian Pac J Cancer Prev, 13, 187-90. https://doi.org/10.7314/APJCP.2012.13.1.187
- Dhir V, Mohandas KM (1999). Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas. Indian J Gastroenterol, 18, 24-8.
- Diehl AK (1983). Gallstone size and the risk of gallbladder cancer. JAMA, 250, 2323-6. https://doi.org/10.1001/jama.1983.03340170049027
- Edge SB, Compton CC (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 17, 1471-4. https://doi.org/10.1245/s10434-010-0985-4
- Gupta P, Agarwal A, Gupta V, et al (2012). Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res, 5, 41-7.
- Kazmi HR, Chandra A, Nigam J, et al (2013). Prognostic significance of K-ras codon 12 mutation in patients with resected gallbladder Cancer. Dig Surg, 30, 233-9. https://doi.org/10.1159/000353133
- Kim J, Jang KT, Kim KH, et al (2010). Aberrant maspin expression is involved in early carcinogenesis of gallbladder cancer. Tumour Biol, 31, 471-6. https://doi.org/10.1007/s13277-010-0056-2
- Kim JH, Kim HN, Lee KT, et al (2008). Gene expression profiles in gallbladder cancer: the close genetic similarity seen for early and advanced gallbladder cancers may explain the poor prognosis. Tumour Biol, 29, 41-9. https://doi.org/10.1159/000132570
- Kumar JR, Tewari M, Rai A, et al (2006). An objective assessment of demography of gallbladder cancer. J Surg Oncol, 93, 610-4. https://doi.org/10.1002/jso.20526
- Lowenfels AB, Walker AM, Althaus DP, Townsend G, Domellof L (1989). Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol, 18, 50-4. https://doi.org/10.1093/ije/18.1.50
- Maass N, Hojo T, Ueding M, et al (2001). Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin Cancer Res, 7, 812-7.
- Maesawa C, Ogasawara S, Yashima-Abo A, et al (2006). Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with Gall stone disease. J Clin Pathol, 59, 328-30. https://doi.org/10.1136/jcp.2005.027284
- Misra S, Chaturvedi A, Misra NC, Sharma ID (2003). Carcinoma of the gallbladder. Lancet Oncol, 4, 167-76. https://doi.org/10.1016/S1470-2045(03)01021-0
- Mohsin SK, Zhang M, Clark GM, Craig Allred D (2003). Maspin expression in invasive breast cancer: Association with other prognostic factors. J Pathol, 199, 432-35. https://doi.org/10.1002/path.1319
- Pandey M, Pathak AK, Gautam A, Aryya NC, Shukla VK (2001). Carcinoma of the Gallbladder. Dig Dis Sci, 46, 1145-51. https://doi.org/10.1023/A:1010652105532
- Randi G, Franceschi S, La Vecchia C (2006). Gallbladder cancer worldwide: Geographical distribution and risk factors. Int J Cancer, 118, 1591-602. https://doi.org/10.1002/ijc.21683
- Shukla VK, Goel S, Trigun SK, Sharma D (2008). Electrophoretic pattern of proteins in carcinoma of the gallbladder. Eur J Cancer Prev, 17, 9-12. https://doi.org/10.1097/CEJ.0b013e3280145e1b
- Singh MK, Chetri K, Pandey UB, et al (2004). Mutational spectrum of K-ras oncogene among Indian patients with gallbladder cancer. J Gastroenterol Hepatol, 19, 916-21. https://doi.org/10.1111/j.1440-1746.2004.03355.x
- Sood AK, Fletcher MS, Gruman LM, et al (2002). The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res, 8, 2924-32.
- Takanami I, Abiko T, Koizumi S (2008). Expression of maspin in non-small-cell lung cancer: correlation with clinical features. Clin Lung Cancer, 9, 361-6. https://doi.org/10.3816/CLC.2008.n.052
- Unisa S, Jagannath P, Dhir V, et al (2011). Population-based study to estimate prevalence and determine risk factors of gallbladder diseases in the rural Gangetic basin of North India. HPB (Oxford), 13, 117-25. https://doi.org/10.1111/j.1477-2574.2010.00255.x
- Volzke H, Baumeister SE, Alte D, et al (2005). Independent risk factors for gallstone formation in a region with high gall stone disease prevalence. Digestion, 71, 97-105. https://doi.org/10.1159/000084525
- Xia W, Lau YK, Hu MC, et al (2000). High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene, 19, 2398-403. https://doi.org/10.1038/sj.onc.1203535
- Wang Y, Sheng S, Zhang J, et al (2013). Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma. Plos One, 8, 63581. https://doi.org/10.1371/journal.pone.0063581
- Zou S, Zhang L (2000). Relative risk factors analysis of 3,922 cases of gallbladder cancer. Zhonghua Wai Ke Za Zhi, 38, 805-8.
- Zou Z, Anisowicz A, Hendrix MJC, et al (1994). Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science, 263, 526-9. https://doi.org/10.1126/science.8290962
피인용 문헌
- Polymorphism and Expression Profile of Cholecystokinin Type A Receptor in Relation to Gallstone Disease Susceptibility vol.54, pp.5, 2016, https://doi.org/10.1007/s10528-016-9745-x
- Significance of methylation status of MASPIN gene and its protein expression in prognosis of gallbladder cancer pp.17437555, 2019, https://doi.org/10.1111/ajco.13129